Cargando…

MicroRNAs associated with therapy of non-small cell lung cancer

Background & Objective: The incidence of non-small cell lung cancer (NSCLC) has been rising over the past several decades. Despite various therapeutic regimens and modern diagnostic techniques are developed, NSCLC still have an extremely poor prognosis due to drug resistance. Therefore, it is cr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Junmi, Zhan, Yuting, Feng, Juan, Luo, Jiadi, Fan, Songqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5930471/ https://www.ncbi.nlm.nih.gov/pubmed/29725260 http://dx.doi.org/10.7150/ijbs.22243

Ejemplares similares

Long non-coding RNAs associated with non-small cell lung cancer
por: Zhan, Yuting, et al.
Publicado: (2017)

The roles of tumor-derived exosomes in non-small cell lung cancer and their clinical implications
por: Zheng, Hongmei, et al.
Publicado: (2018)

Elevated expression of mcl-1 inhibits apoptosis and predicts poor prognosis in patients with surgically resected non-small cell lung cancer
por: Wen, Qiuyuan, et al.
Publicado: (2019)

Expression of DR5 and c-FLIP proteins as novel prognostic biomarkers for non-small cell lung cancer patients treated with surgical resection and chemotherapy
por: Zheng, Hongmei, et al.
Publicado: (2019)

Overexpression of p-Akt, p-mTOR and p-eIF4E proteins associates with metastasis and unfavorable prognosis in non-small cell lung cancer
por: Lu, Junmi, et al.
Publicado: (2020)

Roles of microRNAs in the resistance to platinum based chemotherapy in the non-small cell lung cancer
por: Zang, Hongjing, et al.
Publicado: (2017)

Prognostic analysis of patients with mutant and wild-type EGFR gene lung adenocarcinoma
por: Zheng, Hongmei, et al.
Publicado: (2019)

Overexpression of HSP10 correlates with HSP60 and Mcl-1 levels and predicts poor prognosis in non-small cell lung cancer patients
por: Tang, Yaoxiang, et al.
Publicado: (2021)

Overexpression of p-4EBP1 associates with p-eIF4E and predicts poor prognosis for non-small cell lung cancer patients with resection
por: Tang, Yaoxiang, et al.
Publicado: (2022)

Elevated expression of G3BP1 associates with YB1 and p‐AKT and predicts poor prognosis in nonsmall cell lung cancer patients after surgical resection
por: Zheng, Hongmei, et al.
Publicado: (2019)

Clinical implications of the interaction between PD-1/PD-L1 and PI3K/AKT/mTOR pathway in progression and treatment of non-small cell lung cancer
por: Quan, Zihan, et al.
Publicado: (2022)

Expression of WDR79 is associated with TP53 mutation and poor prognosis in surgically resected non-small cell lung cancer
por: Peng, Jinwu, et al.
Publicado: (2019)

Exosomal microRNAs in non-small cell lung cancer
por: Duréndez-Sáez, Elena, et al.
Publicado: (2021)

Plasma microRNAs as potential biomarkers for non-small-cell lung cancer
por: Shen, Jun, et al.
Publicado: (2011)

YAP1 synergize with YY1 transcriptional co-repress DUSP1 to induce osimertinib resistant by activating the EGFR/MAPK pathway and abrogating autophagy in non-small cell lung cancer
por: Ning, Yue, et al.
Publicado: (2023)

MicroRNAs as regulators of cisplatin-resistance in non-small cell lung carcinomas
por: Fadejeva, Irina, et al.
Publicado: (2017)

Diagnostic and Therapeutic Implications of microRNAs in Non-Small Cell Lung Cancer
por: Ahn, Young-Ho, et al.
Publicado: (2020)

Regulation and therapeutic potentials of microRNAs to non-small cell lung cancer
por: Le, Mai Thi, et al.
Publicado: (2023)

Comprehensive analysis of the mechanism and treatment significance of Mucins in lung cancer
por: Ning, Yue, et al.
Publicado: (2020)

Prognostic value of microRNAs in lung cancer: A systematic review and meta-analysis
por: Xiao, Wendi, et al.
Publicado: (2019)

Exosome-mediated miR-7-5p delivery enhances the anticancer effect of Everolimus via blocking MNK/eIF4E axis in non-small cell lung cancer
por: Liu, Sile, et al.
Publicado: (2022)

Use of recombinant microRNAs as antimetabolites to inhibit human non-small cell lung cancer
por: Chen, Yixin, et al.
Publicado: (2023)

Serum exosomal microRNAs as predictive markers for EGFR mutations in non–small‐cell lung cancer
por: Xia, Junbo, et al.
Publicado: (2021)

MicroRNAs and Long Non-coding RNAs in c-Met-Regulated Cancers
por: Zhan, Hong, et al.
Publicado: (2020)

Beyond Conventional: The New Horizon of Anti-Angiogenic microRNAs in Non-Small Cell Lung Cancer Therapy
por: Tirpe, Alexandru, et al.
Publicado: (2020)

Implications of MicroRNAs in the Treatment of Gefitinib-Resistant Non-Small Cell Lung Cancer
por: Sin, Thomas K., et al.
Publicado: (2016)

Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer
por: Liu, Qingyun, et al.
Publicado: (2016)

Prognostic Value of Survival of MicroRNAs Signatures in Non-small Cell Lung Cancer
por: Chen, Bo, et al.
Publicado: (2019)

Identification of microRNAs that promote erlotinib resistance in non-small cell lung cancer
por: Pal, A.S., et al.
Publicado: (2020)

Cell Behavior of Non-Small Cell Lung Cancer Is at EGFR and MicroRNAs Hands
por: Hassanein, Sarah Sayed, et al.
Publicado: (2021)

Overexpressed p-S6 associates with lymph node metastasis and predicts poor prognosis in non-small cell lung cancer
por: Tang, Yaoxiang, et al.
Publicado: (2022)

Flot-2 Expression Correlates with EGFR Levels and Poor Prognosis in Surgically Resected Non-Small Cell Lung Cancer
por: Wen, Qiuyuan, et al.
Publicado: (2015)

Epigenetic Therapy in Lung Cancer – Role of microRNAs
por: Rothschild, Sacha I.
Publicado: (2013)

MicroRNAs in lung cancer
por: Castro, Diana, et al.
Publicado: (2017)

Circulating MicroRNAs as Non-Invasive Biomarkers for Early Detection of Non-Small-Cell Lung Cancer
por: Wozniak, Magdalena B., et al.
Publicado: (2015)

Exosomal microRNA Therapy for Non-Small-Cell Lung Cancer
por: Chen, Jibing, et al.
Publicado: (2023)

Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer
por: Geng, Qing, et al.
Publicado: (2014)

Circulating microRNAs as novel biomarkers of ALK-positive non-small cell lung cancer and predictors of response to crizotinib therapy
por: Li, Liang-Liang, et al.
Publicado: (2017)

MicroRNA‐based biomarkers for diagnosis of non‐small cell lung cancer (NSCLC)
por: Liao, Jipei, et al.
Publicado: (2020)

Emerging Roles of MicroRNAs in EGFR-Targeted Therapies for Lung Cancer
por: Han, Fei, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_18glh6h1ln4k53oqe365eilg4v